AlphaYouKH
Congress trade
Rep. Kevin Hern (R-OK) bought $250K-$500K of Johnson & Johnson (JNJ) stock
Kevin Hern, U.S. Representative (R-OK), disclosed a purchase of Johnson & Johnson (JNJ) stock worth $250K-$500K in a STOCK Act filing on Jul 14, 2021.
The trade happened on Jun 25, 2021, 19 days before it was made public.
JNJ has moved +55.9% since the trade date, from $164.21 to $256.03 (Oct 2, 2026 close).
- Traded
- Jun 25, 2021
- Disclosed
- Jul 14, 2021
- Filing delay
- 19 days
- Price since
- +55.9%
- Source
- STOCK Act disclosure
Other trades in this disclosure (17)
- BuyPXD$500K-$1MJul 14, 2021
- BuyJPM$250K-$500KJul 14, 2021
- BuyMSFT$250K-$500KJul 14, 2021
- BuyACN$100K-$250KJul 14, 2021
- BuyASXC$100K-$250KJul 14, 2021
- BuyLIN$100K-$250KJul 14, 2021
- BuyMASI$100K-$250KJul 14, 2021
- BuyMSFT$100K-$250KJul 14, 2021
- BuyHON$50K-$100KJul 14, 2021
- BuyMASI$15K-$50KJul 14, 2021
- BuyPSX$15K-$50KJul 14, 2021
- BuyDVN$1K-$15KJul 14, 2021
- BuyHD$1K-$15KJul 14, 2021
- BuyMSFT$1K-$15KJul 14, 2021
- BuyNEE$1K-$15KJul 14, 2021
- BuyWMB$1K-$15KJul 14, 2021
- BuyXOM$1K-$15KJul 14, 2021
More JNJ insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.